429 related articles for article (PubMed ID: 26044701)
1. Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial.
Moniche F; Escudero I; Zapata-Arriaza E; Usero-Ruiz M; Prieto-León M; de la Torre J; Gamero MA; Tamayo JA; Ochoa-Sepúlveda JJ; Maestre J; Carmona M; Piñero P; Calderón-Cabrera C; Jimenez MD; Gonzalez A; Montaner J
Int J Stroke; 2015 Oct; 10(7):1149-52. PubMed ID: 26044701
[TBL] [Abstract][Full Text] [Related]
2. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial.
Moniche F; Gonzalez A; Gonzalez-Marcos JR; Carmona M; Piñero P; Espigado I; Garcia-Solis D; Cayuela A; Montaner J; Boada C; Rosell A; Jimenez MD; Mayol A; Gil-Peralta A
Stroke; 2012 Aug; 43(8):2242-4. PubMed ID: 22764211
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial.
Moniche F; Cabezas-Rodriguez JA; Valverde R; Escudero-Martinez I; Lebrato-Hernandez L; Pardo-Galiana B; Ainz L; Medina-Rodriguez M; de la Torre J; Escamilla-Gomez V; Ortega-Quintanilla J; Zapata-Arriaza E; de Albóniga-Chindurza A; Mancha F; Gamero MA; Perez S; Espinosa-Rosso R; Forero-Diaz L; Moya M; Piñero P; Calderón-Cabrera C; Nogueras S; Jimenez R; Martin V; Delgado F; Ochoa-Sepúlveda JJ; Quijano B; Mata R; Santos-González M; Carmona-Sanchez G; Herrera C; Gonzalez A; Montaner J
Lancet Neurol; 2023 Feb; 22(2):137-146. PubMed ID: 36681446
[TBL] [Abstract][Full Text] [Related]
4. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial.
Prasad K; Sharma A; Garg A; Mohanty S; Bhatnagar S; Johri S; Singh KK; Nair V; Sarkar RS; Gorthi SP; Hassan KM; Prabhakar S; Marwaha N; Khandelwal N; Misra UK; Kalita J; Nityanand S;
Stroke; 2014 Dec; 45(12):3618-24. PubMed ID: 25378424
[TBL] [Abstract][Full Text] [Related]
5. Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial.
Schellinger PD; Alexandrov AV; Barreto AD; Demchuk AM; Tsivgoulis G; Kohrmann M; Alleman J; Howard V; Howard G; Alexandrov AW; Brandt G; Molina CA;
Int J Stroke; 2015 Oct; 10(7):1141-8. PubMed ID: 26120902
[TBL] [Abstract][Full Text] [Related]
6. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
[TBL] [Abstract][Full Text] [Related]
7. Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke.
Battistella V; de Freitas GR; da Fonseca LM; Mercante D; Gutfilen B; Goldenberg RC; Dias JV; Kasai-Brunswick TH; Wajnberg E; Rosado-de-Castro PH; Alves-Leon SV; Mendez-Otero R; Andre C
Regen Med; 2011 Jan; 6(1):45-52. PubMed ID: 21175286
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNA after autologous bone marrow mononuclear cell (BM-MNC) injection in patients with ischemic stroke.
Mancha F; Escudero-Martinez I; Zapata-Arriaza E; Vega-Salvatierra A; Cabezas JA; Lebrato L; Pardo B; De-La-Torre J; Zapata M; Escamilla V; Calderón-Cabrera C; Martín-Sánchez J; Valverde R; Aguera-Morales E; Herrera I; Delgado F; Gamero MÁ; Pérez-Sánchez S; Moya M; Espinosa R; Ortega-Quintanilla J; Gutierrez-Jarrin I; González-García A; Montaner J; Moniche F
J Investig Med; 2020 Mar; 68(3):807-810. PubMed ID: 31852749
[TBL] [Abstract][Full Text] [Related]
9. A double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke.
Hess DC; Sila CA; Furlan AJ; Wechsler LR; Switzer JA; Mays RW
Int J Stroke; 2014 Apr; 9(3):381-6. PubMed ID: 23692637
[TBL] [Abstract][Full Text] [Related]
10. Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial.
Vahidy FS; Haque ME; Rahbar MH; Zhu H; Rowan P; Aisiku IP; Lee DA; Juneja HS; Alderman S; Barreto AD; Suarez JI; Bambhroliya A; Hasan KM; Kassam MR; Aronowski J; Gee A; Cox CS; Grotta JC; Savitz SI
Stem Cells; 2019 Nov; 37(11):1481-1491. PubMed ID: 31529663
[TBL] [Abstract][Full Text] [Related]
11. Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke.
Friedrich MA; Martins MP; Araújo MD; Klamt C; Vedolin L; Garicochea B; Raupp EF; Sartori El Ammar J; Machado DC; Costa JC; Nogueira RG; Rosado-de-Castro PH; Mendez-Otero R; Freitas GR
Cell Transplant; 2012; 21 Suppl 1():S13-21. PubMed ID: 22507676
[TBL] [Abstract][Full Text] [Related]
12. A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke).
Savitz SI; Yavagal D; Rappard G; Likosky W; Rutledge N; Graffagnino C; Alderazi Y; Elder JA; Chen PR; Budzik RF; Tarrel R; Huang DY; Hinson JM
Circulation; 2019 Jan; 139(2):192-205. PubMed ID: 30586746
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal Injection of Allogenic Bone Marrow-Derived Mesenchymal Stromal Cells in Treatment of Patients with Severe Ischemic Stroke: Study Protocol for a Randomized Controlled Observer-Blinded Trial.
Deng L; Peng Q; Wang H; Pan J; Zhou Y; Pan K; Li J; Wu Y; Wang Y
Transl Stroke Res; 2019 Apr; 10(2):170-177. PubMed ID: 29796934
[TBL] [Abstract][Full Text] [Related]
14. Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats.
Brenneman M; Sharma S; Harting M; Strong R; Cox CS; Aronowski J; Grotta JC; Savitz SI
J Cereb Blood Flow Metab; 2010 Jan; 30(1):140-9. PubMed ID: 19773802
[TBL] [Abstract][Full Text] [Related]
15. Intra-arterial bone marrow mononuclear cell transplantation correlates with GM-CSF, PDGF-BB, and MMP-2 serum levels in stroke patients: results from a clinical trial.
Moniche F; Montaner J; Gonzalez-Marcos JR; Carmona M; Piñero P; Espigado I; Cayuela A; Escudero I; de la Torre-Laviana FJ; Boada C; Rosell A; Mayol A; Jimenez MD; Gil-Peralta A; Gonzalez A
Cell Transplant; 2014; 23 Suppl 1():S57-64. PubMed ID: 25335778
[TBL] [Abstract][Full Text] [Related]
16. Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial.
Hong JM; Choi MH; Sohn SI; Hwang YH; Ahn SH; Lee YB; Shin DI; Chamorro Á; Choi DW;
Trials; 2018 Jul; 19(1):375. PubMed ID: 30005644
[TBL] [Abstract][Full Text] [Related]
17. CHIMES-I: sub-group analyzes of the effects of NeuroAiD according to baseline brain imaging characteristics among patients randomized in the CHIMES study.
Navarro JC; Chen CL; Lagamayo PD; Geslani MB; Eow GB; Poungvarin N; de Silva A; Wong LK; Venketasubramanian N;
Int J Stroke; 2013 Aug; 8(6):491-4. PubMed ID: 23506216
[TBL] [Abstract][Full Text] [Related]
18. NeuroThera® Efficacy and Safety Trial-3 (NEST-3): a double-blind, randomized, sham-controlled, parallel group, multicenter, pivotal study to assess the safety and efficacy of transcranial laser therapy with the NeuroThera® Laser System for the treatment of acute ischemic stroke within 24 h of stroke onset.
Zivin JA; Sehra R; Shoshoo A; Albers GW; Bornstein NM; Dahlof B; Kasner SE; Howard G; Shuaib A; Streeter J; Richieri SP; Hacke W;
Int J Stroke; 2014 Oct; 9(7):950-5. PubMed ID: 23013107
[TBL] [Abstract][Full Text] [Related]
19. Intra-Arterial Injection of Autologous Bone Marrow-Derived Mononuclear Cells in Ischemic Stroke Patients.
Hammadi AMA; Alhimyari F
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):239-241. PubMed ID: 30777565
[TBL] [Abstract][Full Text] [Related]
20. Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke.
Shichinohe H; Kawabori M; Iijima H; Teramoto T; Abumiya T; Nakayama N; Kazumata K; Terasaka S; Arato T; Houkin K
BMC Neurol; 2017 Sep; 17(1):179. PubMed ID: 28886699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
